{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T14:25:46Z","timestamp":1759847146597},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,11]],"date-time":"2017-02-11T00:00:00Z","timestamp":1486771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.rgmx.2016.10.006","type":"journal-article","created":{"date-parts":[[2017,3,12]],"date-time":"2017-03-12T04:45:54Z","timestamp":1489293954000},"page":"226-233","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Susceptibilidad a la rifaximina y otros antimicrobianos de bacterias aisladas en pacientes con infecciones gastrointestinales agudas en el sureste de M\u00e9xico"],"prefix":"10.1016","volume":"82","author":[{"given":"O.","family":"Novoa-Farias","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.C.","family":"Frati-Munari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Peredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Flores-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Novoa-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Galicia-Tapia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.E.","family":"Romero-Carpio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rgmx.2016.10.006_bib0190","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/MCG.0b013e31826df662","article-title":"Acute diarrhea in adults and children: A global perspective","volume":"47","author":"Farthing","year":"2013","journal-title":"J Clin Gastroenterol."},{"key":"10.1016\/j.rgmx.2016.10.006_bib0195","first-page":"118","article-title":"Enfermedad diarreica aguda en ni\u00f1os menores de cinco a\u00f1os de edad: aportaci\u00f3n de los n\u00facleos trazadores de vigilancia epidemiol\u00f3gica. 2012-2013","volume":"5","author":"Cabrera- Gayt\u00e1n","year":"2013","journal-title":"Arch Invest Mat Infant"},{"issue":"Supl. 2","key":"10.1016\/j.rgmx.2016.10.006_bib0200","doi-asserted-by":"crossref","first-page":"314","DOI":"10.21149\/spm.v55s2.5130","article-title":"Diarreas agudas y pr\u00e1cticas de alimentaci\u00f3n en ni\u00f1os menores de cinco a\u00f1os en M\u00e9xico","volume":"55","author":"Ferreira","year":"2013","journal-title":"Salud Pub Mex"},{"key":"10.1016\/j.rgmx.2016.10.006_bib0205","unstructured":"Secretaria de Salud. Enfermedades diarreicas agudas. Prevenci\u00f3n, control y tratamiento. M\u00e9xico: Secretar\u00eda de Salud; 2010."},{"key":"10.1016\/j.rgmx.2016.10.006_bib0210","first-page":"137","article-title":"Situaci\u00f3n de las enfermedades gastrointestinales en M\u00e9xico","volume":"31","author":"Hern\u00e1ndez Cortez","year":"2011","journal-title":"Enf Inf Microbiol"},{"key":"10.1016\/j.rgmx.2016.10.006_bib0215","first-page":"3","article-title":"Susceptibilidad de las bacterias aisladas de infecciones gastrointestinales agudas a la rifaximina y otros agentes antimicrobianos en M\u00e9xico","volume":"81","author":"Novoa-Far\u00eda","year":"2016","journal-title":"Rev Gastroenterol Mex."},{"issue":"Suppl 1","key":"10.1016\/j.rgmx.2016.10.006_bib0220","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000089776","article-title":"Experimental and clinical pharmacology of rifaximin, a gastrointestinal selective antibiotic","volume":"73","author":"Scarpignato","year":"2006","journal-title":"Digestion"},{"key":"10.1016\/j.rgmx.2016.10.006_bib0225","series-title":"Diagnostic microbiology","first-page":"131","author":"Koneman","year":"2000"},{"key":"10.1016\/j.rgmx.2016.10.006_bib0230","unstructured":"Clinical Laboratory Standards Institute.Performance Standards for Antimicrobial Susceptibility Testing. 22 information supplement. M-100-522,2013.32(3)."},{"key":"10.1016\/j.rgmx.2016.10.006_bib0235","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1128\/AAC.45.1.212-216.2001","article-title":"In vitro antimicrobial susceptibility testing of bacterial enteropathogens causing traveler's diarrhea in four geographic regions","volume":"45","author":"Gomi","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.rgmx.2016.10.006_bib0240","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1128\/AAC.00739-10","article-title":"In vitro antimicrobial susceptibility of bacterial enteropathogens isolated from international traveler's to Mexico, Guatemala, and India from 2006 to 2008","volume":"55","author":"Ouyang-Latimer","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.rgmx.2016.10.006_bib0245","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ijantimicag.2014.01.026","article-title":"In vitro activity of rifaximin against clinical isolates od Escherichia coli and other enteropathogenic bacteria isolated from travelers returning to the UK","volume":"43","author":"Hopkins","year":"2014","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.rgmx.2016.10.006_bib0250","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1128\/AAC.44.8.2205-2206.2000","article-title":"In vitro activity and fecal concentration of rifaximin after oral administration","volume":"44","author":"Jiang","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.rgmx.2016.10.006_bib0255","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1128\/JCM.02460-08","article-title":"Surveillance of antibiotic susceptibility patterns among Shigella sonnei strains isolated in Belgium during the 18-year period 1990 to 2007","volume":"47","author":"Vrints","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.rgmx.2016.10.006_bib0260","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/cid\/ciu957","article-title":"Antimicrobial increase travelers\u2019 risk of colonization by extended-spectrum betalactamase-producing Enterobacteriaceae","volume":"60","author":"Cantele","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.rgmx.2016.10.006_bib0265","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1093\/clinids\/24.Supplement_1.S102","article-title":"Antimicrobial resistance in organisms causing diarrheal disease","volume":"24","author":"Sack","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rgmx.2016.10.006_bib0270","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0213-005X(01)72702-4","article-title":"Fosfomicina. Un antibi\u00f3tico infravalorado en infecciones urinarias por E. coli","volume":"19","author":"Garau","year":"2001","journal-title":"Enf Inf MicrobiolClin"},{"issue":"Suppl 1","key":"10.1016\/j.rgmx.2016.10.006_bib0275","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000081991","article-title":"Rifaximin: In vitro and in vivo antibacterial activity-A review","volume":"51","author":"Jiang","year":"2005","journal-title":"Chemotherapy"},{"key":"10.1016\/j.rgmx.2016.10.006_bib0280","first-page":"979","article-title":"Rapid disappearance from the intestinal tract of bacteria resistant to rifaximin","volume":"12","author":"De Leo","year":"1986","journal-title":"Drugs Exptl Clin Res"},{"key":"10.1016\/j.rgmx.2016.10.006_bib0285","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1469-0691.2004.00997.x","article-title":"Influence of rifaximin treatment on the susceptibility of intestinal Gram-negative flora and enterococci","volume":"10","author":"Dupont","year":"2004","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.rgmx.2016.10.006_bib0290","first-page":"61","article-title":"Effect of rifaximin on bacterial virulence mechanisms at supr and sub-inhibitory concentration","volume":"29","author":"Debbia","year":"2008","journal-title":"J Chemother"},{"key":"10.1016\/j.rgmx.2016.10.006_bib0295","first-page":"23","article-title":"Eficacia y seguridad de rifaximina en el tratamiento del episodio diarreico agudo en ni\u00f1os de seis meses a cinco a\u00f1os","volume":"16","author":"Mac\u00edas Parra","year":"2002","journal-title":"Rev Enf Inf Pediat"},{"key":"10.1016\/j.rgmx.2016.10.006_bib0300","first-page":"336","article-title":"Infectious diarrhea in the aged: Controlled clinical trial of rifaximin","volume":"7","author":"Della Marchina","year":"1988","journal-title":"Chemother"},{"key":"10.1016\/j.rgmx.2016.10.006_bib0305","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.4269\/ajtmh.2006.74.1060","article-title":"A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of traveler diarrhea","volume":"74","author":"Taylor","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.rgmx.2016.10.006_bib0310","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cgh.2007.02.004","article-title":"Treatment of travelers\u2019diarrhea: A randomized trial comparing rifaximin, rifaximin plus loperamide and loperamide alone","volume":"5","author":"DuPont","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmx.2016.10.006_bib0315","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1086\/511870","article-title":"Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin","volume":"44","author":"Johnson","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rgmx.2016.10.006_bib0320","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1708-8305.2006.00084.x","article-title":"Rifaximin treatment of pathogen-negative travelers\u2019 diarrhea","volume":"14","author":"DuPont","year":"2007","journal-title":"J Travel Med"},{"key":"10.1016\/j.rgmx.2016.10.006_bib0325","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1053\/j.gastro.2013.10.026","article-title":"Rifaximin alters intestinal bacteria and prevent stress-induced gut inflammation and visceral hyperalgesia in rats","volume":"146","author":"Xue","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.rgmx.2016.10.006_bib0330","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1128\/AAC.00691-09","article-title":"Pretreatment of epithelial cells with rifaximin alters bacterial attachment and internalization profiles","volume":"54","author":"Brown","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.rgmx.2016.10.006_bib0335","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000068362","article-title":"Inhibition of intestinal bacterial translocation with rifaximin modulates lamina propria monocytic cells reactivity and protects against inflammation in a rodent model of colitis","volume":"66","author":"Fiorucci","year":"2002","journal-title":"Digestion"},{"key":"10.1016\/j.rgmx.2016.10.006_bib0340","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/jpet.110.170225","article-title":"Therapeutic role of rifaximin in inflammatory bowel disease: Clinical implication of human pregnane X receptor activation","volume":"335","author":"Cheng","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.rgmx.2016.10.006_bib0345","doi-asserted-by":"crossref","first-page":"e60042","DOI":"10.1371\/journal.pone.0060042","article-title":"Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy","volume":"8","author":"Bajaj","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.rgmx.2016.10.006_bib0350","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1086\/591126","article-title":"Emergency department visits for antibiotic associated adverse events","volume":"47","author":"Shehab","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.rgmx.2016.10.006_bib0355","unstructured":"Gu\u00eda de pr\u00e1ctica cl\u00ednica. Prevenci\u00f3n, diagn\u00f3stico y tratamiento de la diarrea aguda en ni\u00f1os de dos meses a cinco a\u00f1os en el primero y segundo nivel de atenci\u00f3n. Cat\u00e1logo maestro de gu\u00edas de pr\u00e1ctica cl\u00ednica. SSA-156-08 [consultado 23 Oct 2015]. Disponible en: www.cenetec.salud.gob.mx"},{"key":"10.1016\/j.rgmx.2016.10.006_bib0360","unstructured":"Gu\u00eda de pr\u00e1ctica cl\u00ednica. Atenci\u00f3n, diagn\u00f3stico y tratamiento de la diarrea aguda en adultos en el primer nivel de atenci\u00f3n. Cat\u00e1logo maestro de pr\u00e1ctica cl\u00ednica SSA 106-08 [consultado 28 Oct 2015]. Disponible en: www.cenetec.salud.gob.mx"},{"key":"10.1016\/j.rgmx.2016.10.006_bib0365","first-page":"1","article-title":"Reflexiones sobre la resistencia a antibi\u00f3ticos y que hacer al respecto","volume":"81","author":"Remes Troche","year":"2016","journal-title":"Rev Gastroenterol Mex"},{"key":"10.1016\/j.rgmx.2016.10.006_bib0370","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(15)00520-6","article-title":"Exploring the evidence base for national and regional policy intervention to combat resistance","volume":"387","author":"Dar","year":"2016","journal-title":"Lancet"}],"container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0375090617300216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0375090617300216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T16:52:40Z","timestamp":1568911960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0375090617300216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0375090617300216"],"URL":"https:\/\/doi.org\/10.1016\/j.rgmx.2016.10.006","relation":{},"ISSN":["0375-0906"],"issn-type":[{"value":"0375-0906","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Susceptibilidad a la rifaximina y otros antimicrobianos de bacterias aisladas en pacientes con infecciones gastrointestinales agudas en el sureste de M\u00e9xico","name":"articletitle","label":"Article Title"},{"value":"Revista de Gastroenterolog\u00eda de M\u00e9xico","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmx.2016.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda. Published by Masson Doyma M\u00e9xico S.A.","name":"copyright","label":"Copyright"}]}}